Get the Stockscreener App
5.545
0.09%
0.005
After Hours:
5.55
0.005
+0.09%
Regencell Bioscience Holdings Ltd stock is traded at $5.545, with a volume of 7,311.
It is up +0.09% in the last 24 hours and down -23.31% over the past month.
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.
See More
Previous Close:
$5.54
Open:
$5.8
24h Volume:
7,311
Relative Volume:
0.04
Market Cap:
$72.16M
Revenue:
-
Net Income/Loss:
$-5.87M
P/E Ratio:
-10.27
EPS:
-0.54
Net Cash Flow:
$-767.30K
1W Performance:
-4.40%
1M Performance:
-23.31%
6M Performance:
+23.22%
1Y Performance:
-61.09%
1-Day Range:
$5.399
$5.80
1-Week Range:
$5.399
$6.4398
52-Week Range:
$3.03
$32.44
Regencell Bioscience Holdings Ltd Stock (RGC) Company Profile
Regencell Bioscience Holdings Ltd Stock (RGC) Latest News
Regencell Bioscience (NASDAQ:RGC) Stock Quotes, Forecast and News Summary - Benzinga
Regeneron slides as Amgen wins Eylea biosimilar case; RBC still bullish - Investing.com
Geron: Derisked And Highly Attractive After Approval (NASDAQ:GERN) - Seeking Alpha
Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines Conference - StockTitan
RBC says Regeneron reaction to biosimilar court ruling ‘overdone’ - TipRanks
Insider’s View: Deciphering Regenxbio Inc (RGNX)’s Financial Health Through Ratios - The Dwinnex
Xponance Inc. Lowers Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
40 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Bought by Itau Unibanco Holding S.A. - Defense World
Morse Asset Management Inc Increases Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Regency Centers Co. (NASDAQ:REG) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
ProShare Advisors LLC Decreases Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Is Regenx Tech (CSE:RGX) Using Too Much Debt? - Simply Wall St
Benjamin F. Edwards & Company Inc. Purchases 612 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Profund Advisors LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Legacy Financial Advisors Inc. Purchases 69 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Ensign Peak Advisors Inc Cuts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Ieq Capital LLC Purchases 507 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Trust Investment Advisors Acquires Shares of 192 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
ASB Consultores LLC Cuts Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
SYSTM Wealth Solutions LLC Sells 1,244 Shares of Regency Centers Co. (NASDAQ:REG) - Defense World
Intech Investment Management LLC Increases Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
MRP Capital Investments LLC Takes Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Meiji Yasuda Asset Management Co Ltd. Purchases 119 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Moors & Cabot Inc. Has $858,000 Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Wealth Alliance Sells 13 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Argent Trust Co Has $2.49 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Defense World
Meiji Yasuda Life Insurance Co Sells 2,609 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Envestnet Asset Management Inc. - Defense World
Regency Centers (NASDAQ:REG) Stock Rating Lowered by Evercore ISI - Defense World
RGC’s 52-Week Rollercoaster: From $3.03 to $32.44 – What’s Next for Investors? - The InvestChronicle
Regencell Bioscience Holdings Ltd Inc. (RGC) Price Performance: How to Use Technical Analysis to Make Trading Decisions - The InvestChronicle
Stock Market Recap: Regencell Bioscience Holdings Ltd (RGC) Concludes at 8.16, a 23.26 Surge/Decline - The Dwinnex
Regencell Bioscience Holdings Ltd (RGC) Stock: Navigating a Year of Volatility - The InvestChronicle
Wall Street today: US stocks trade higher after promising inflation data raises Fed rate cut bets; 3M Co. gains 18.99% - MSN
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session - Benzinga
Wall Street today: US stocks trade higher after promising inflation data raises Fed rate cut bets; 3M Co. gains 18.99% | Stock Market News - Mint
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Benzinga
Regencell Bioscience Holdings Limited's (NASDAQ:RGC) most bullish insider, CEO Yat-Gai Au must be pleased with the recent 321% gain - Simply Wall St
Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
RGC’s Market Flip-Flop: Exploring the Volatility of 2023 Performance - The InvestChronicle
Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Salarius Pharmaceuticals (SLRX) drops 21% and here’s why - BP Journal
Azitra (AZTR) Makes Strides with New Patents and Public Offering - BP Journal
Regencell Bioscience Holdings Ltd (NASDAQ: RGC) Surges: What’s Behind the Spike? - BP Journal
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.14% - Investing.com
United States shares lower at close of trade; Dow Jones Industrial Average down 0.14% - Investing.com India
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Benzinga
Regencell Bioscience Holdings hits 52-week high, reaching $23.89 - Investing.com India
Metrion Biosciences Appoints Dr Chris Mathes as Chief Commercial Officer - Yahoo Finance
What Is Going on With Regencell Bioscience (RGC) Stock Today? - InvestorPlace
Regencell Bioscience Holdings Ltd Stock (RGC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.23%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):